Home/Filings/4/0001209191-18-009158
4//SEC Filing

Patel Paresh 4

Accession 0001209191-18-009158

CIK 0001400810other

Filed

Feb 11, 7:00 PM ET

Accepted

Feb 12, 3:50 PM ET

Size

14.3 KB

Accession

0001209191-18-009158

Insider Transaction Report

Form 4
Period: 2018-02-08
Patel Paresh
DirectorExecutive Chairman
Transactions
  • Award

    Common Stock

    2018-02-08+40,00040,000 total
  • Award

    Stock Option (Right to Buy)

    2018-02-08+110,000110,000 total
    Exercise: $40.00Exp: 2028-02-08Common (110,000 underlying)
Holdings
  • Common stock

    (indirect: By IRA)
    35,000
  • Common stock

    300,000
  • Common stock

    438,000
  • Common Stock

    40,000
  • Stock Option (Right to Buy)

    Exercise: $40.00Exp: 2027-01-07Common (110,000 underlying)
    110,000
  • Common Stock

    74,000
Footnotes (7)
  • [F1]Restricted stock grant of 400,000 shares effective 5/16/2013: the Issuer cancelled effective 3/2/2016 a 100,000 share tranche of this grant that was to have vested one year after the closing price of HCI common shares equaled or exceeded $50 per share for 20 consecutive trading days. Of the award's 300,000 remaining shares, 100,000 have previously vested, 100,000 shares will vest one year after the closing price of HCI common shares equals or exceeds $65 per share for 20 consecutive trading days, and 100,000 will vest one year after the closing price of HCI common shares equals or exceeds $80 per share for 20 consecutive trading days. All shares for which restrictions have not lapsed 6 years and one day from the grant date will be forfeited. These shares were granted by the Company pursuant to the Company's 2012 Omnibus Incentive Plan and under the terms and conditions of a restricted stock agreement dated 5/16/2013.
  • [F2]Shares held jointly with spouse.
  • [F3]Restricted stock grant of 40,000 shares effective January 7, 2017: Restrictions on 10,000 shares will lapse on each of January 7, 2018, January 7, 2019, January 7, 2020, and January 7, 2021. These shares were granted by the Company pursuant to the Company's 2012 Omnibus Incentive Plan and under the terms and conditions of a restricted stock award contract dated January 7, 2018.
  • [F4]Restricted stock grant of 40,000 shares effective February 8, 2018: Restrictions on 10,000 shares will lapse on each of February 8, 2019, February 8, 2020, February 8, 2021, and February 8, 2022. These shares were granted by the Company pursuant to the Company's 2012 Omnibus Incentive Plan and under the terms and conditions of a restricted stock award contract dated February 8, 2018.
  • [F5]The options were granted pursuant to the HCI Group, Inc. 2012 Omnibus Incentive Plan.
  • [F6]The options were granted on January 7, 2017 at an exercise price of $40.00 per share, in excess of the $39.71 market value. Commencing on January 7, 2018 and continuing on the same day of each calendar year thereafter through and including January 7, 2021, the amount of 27,500 options will vest and become exercisable on each such annual vesting date. Once vested, the options may be exercised at any time up to and including January 7, 2027.
  • [F7]The options were granted on February 8, 2018 at an exercise price of $40.00 per share, in excess of the $34.92 market value. Commencing on February 8, 2019 and continuing on the same day of each calendar year thereafter through and including February 8, 2022, the amount of 27,500 options will vest and become exercisable on each such annual vesting date. Once vested, the options may be exercised at any time up to and including February 8, 2028.

Issuer

HCI Group, Inc.

CIK 0001400810

Entity typeother

Related Parties

1
  • filerCIK 0001439934

Filing Metadata

Form type
4
Filed
Feb 11, 7:00 PM ET
Accepted
Feb 12, 3:50 PM ET
Size
14.3 KB